AI and sensors aim to predict surgery risks for rare tumors

NCT ID NCT07516275

First seen Apr 30, 2026 · Last updated May 10, 2026 · Updated 2 times

Summary

This study enrolls 200 adults scheduled for surgery to remove pheochromocytoma or paraganglioma tumors. Researchers will test a model that uses 6 factors to predict severe blood pressure swings during the operation, and a real-time tool that warns of changes 60 seconds ahead. Participants wear a continuous glucose monitor and undergo an AI-based anesthesia check, but their standard care is not changed. The goal is to improve safety and understanding of these risky surgeries.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.